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pt received November 4,his study sought to analyze cardiac magnetic resonance (CMR) measurements of myocardial extracellular volume
fraction (ECV) and late gadolinium enhancement (LGE) in children and young adults with congenital aortic stenosis
(AS) to determine the extent of ﬁbrosis and examine their association with aortic valve and ventricular function.Background Patients with congenital AS frequently have impaired diastolic ventricular function and exercise capacity that may
be related to myocardial ﬁbrosis.Methods A total of 35 patients with congenital AS (median age 16 years) and 27 normal control subjects (median age 16
years) were evaluated by CMR. ECV was calculated from pre- and post-gadolinium contrast T1 measurements of
blood and myocardium, and the hematocrit.Results ECV was signiﬁcantly higher in AS patients than in normal subjects (median 0.27 [range 0.22 to 0.42] vs. 0.25
[range 0.18 to 0.27], p ¼ 0.001). LGE was present in 8 (24%) of the AS patients. A higher ECV was correlated with
echocardiographic indexes of diastolic dysfunction including a higher mitral E-wave z-score (r ¼ 0.58, p ¼ 0.002),
E/septal E0 z-score (r ¼ 0.56, p ¼ 0.003), E/mean E0 z-score (r ¼ 0.55, p ¼ 0.003), and indexed left atrial volume
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1779been used to detect focal regions of myocardial ﬁbrosis (5).
More recently, a CMR technique based on measurements
of T1 relaxation times before and after gadolinium admin-
istration has been developed to determine the myocardial
extracellular volume fraction (ECV) in order to assess diffuse
ﬁbrosis (6,7). ECV by this technique correlates with myo-
cardial collagen fraction quantiﬁed by histopathology
in murine hypertension models (8,9) and in adults with
AS (10).
These CMR techniques provide an avenue of insight into
the pathophysiology of congenital AS that has yet to be
explored. Accordingly, the goals of this study were to use the
newly-developed CMR measurement of myocardial ECV as
well as LGE to determine the prevalence and extent of
myocardial ﬁbrosis in children and young adults with
congenital AS, and to examine the association of ECV and
LGE with parameters of left ventricular (LV) systolic and
diastolic function, aortic valve function, exercise capacity,
and clinical history.Methods
Subjects. A retrospective database search identiﬁed all AS
subjects who fulﬁlled the following criteria: 1) had a CMR
examination at Boston Children’s Hospital with a myocar-
dial ECV measurement; 2) were <30 years of age; and
3) had congenital AS with an echocardiographic peak
Doppler gradient 20 mm Hg at any time prior to the
CMR examination. Subjects with aortic regurgitation or
with a history of surgical or catheter interventions on the
aortic valve were included. Demographic, clinical, and pro-
cedural data were abstracted from the medical record.
Control subjects came from Boston Children’s Hospital
and from the University Hospital of Schleswig-Holstein,
Kiel, Germany. In Boston, a retrospective database search
identiﬁed 22 patients who underwent a CMR examination
with a myocardial ECV measurement, were <30 years of
age, had a normal CMR examination, and had no history of
left-sided heart disease or cardiomyopathy. In Kiel, 5 control
subjects were recruited prospectively from among patients
scheduled to undergo clinically-indicated brain magnetic
resonance imaging with administration of a gadolinium-
based contrast agent. They were all <30 years of age, had
a normal CMR examination, and had no history of left-
sided heart disease or cardiomyopathy.
The study protocol was approved by the Institutional
Review Boards at Boston Children’s Hospital and at Uni-
versity Hospital of Schleswig-Holstein.
Cardiac magnetic resonance. CMR examinations in AS
and control subjects were performed on a 1.5-T scanner
(Philips Achieva, Philips Healthcare, Best, the Netherlands).
Young patients who were unable to cooperate sufﬁciently
were examined under general anesthesia.
T1 measurements for ECV calculation were obtained
using a previously-described Look-Locker technique with
bolus contrast administration (7). This approach wasselected because its accuracy and
reproducibility have been estab-
lished (11). Moreover, compared
with a modiﬁed Look-Locker
inversion recovery approach (12),
this technique has more complete
sampling of the T1 recovery curve
and is potentially less affected by
heart rate (13). The latter point
was particularly important be-
cause a relatively broad range
of heart rates was expected, given
that both pediatric and adult
subjects are referred for CMR
studies. An electrocardiogram-
gated breath-hold Look-Locker sequence with a segmented
gradient echo cine acquisition was performed at a single
midventricular short-axis slice once prior to contrast admin-
istration and 3 times following contrast (5-min post-contrast,
10-min post-contrast, and at the end of the examination).
Gadopentetate dimeglumine (Magnevist, Bayer HealthCare
Pharmaceuticals, Wayne, New Jersey) was used for contrast,
with a bolus dose of 0.2 mmol/kg for patients <20 kg and
0.15 mmol/kg for patients 20 kg. Signal intensity versus
time curves were generated for 6 equal sectors of the LV
myocardium and the blood pool using commercially-
available software (QMASS MR, Medis Medical Imag-
ing Systems, Leiden, the Netherlands). Myocardium with
LGE was excluded from the region of interest. From
these curves, the T1 values were calculated by ﬁtting to an
analytical expression for the inversion recovery signal in-
tensity. The myocardial R1 (R1 ¼ 1/T1) was plotted against
the blood pool R1. The slope of this relationship deﬁnes the
partition coefﬁcient for gadolinium (l) (8). The myocardial
ECV was then computed using the following equation:
ECV ¼ l(1  hematocrit expressed as a fraction) (7).
LGE imaging was performed 15 min after contrast
administration using a standard 2-dimensional breath-hold
phase-sensitive inversion recovery sequence with the inver-
sion time selected to null the myocardial signal. Images were
acquired in multiple long- and short-axis ventricular planes
to encompass the entire myocardium. The images were later
systematically reviewed, and the number of enhancing LV
segments (17-segment model) and the pattern (full thick-
ness, mid-wall, subendocardial, subepicardial) were recorded.
LV end-diastolic volume, end-systolic volume, ejection
fraction, and mass were measured from a stack of cine
steady-state free precession short-axis images in a standard
fashion (14). Left atrial (LA) volume was calculated from
horizontal and vertical long-axis ventricular views using the
biplane area-length method (15).
Echocardiography. The echocardiogram closest in time to
the CMR examination was reviewed for each subject. Pulsed-
wave and tissue Doppler parameters were measured 3 times
by a single observer, averaged, and converted to z-scores to
adjust for the effect of age. Age-based normative values were
Table 1 Subject Characteristics (n ¼ 35)
Age at CMR, yrs 16.0 (1.7–27)
Male patients 29 (83)
Diagnosis
AS 25 (71)
AS and coarctation 6 (17)
AS and mitral stenosis 2 (6)
AS, mitral stenosis, and coarctation 2 (6)
Highest aortic valve peak Doppler gradient, mm Hg 70 (22–110)
Prior balloon aortic valvuloplasty 21 (60)
Age at ﬁrst balloon aortic valvuloplasty, yrs 0.2 (0–15)
Prior surgical intervention on the aortic valve 16 (46)
Age at initial aortic valve procedure, yrs 5.2 (0–19.5)
Values are median (range) or n (%).
AS ¼ aortic stenosis; CMR ¼ cardiac magnetic resonance.
Table 2
Echocardiography and CMR Parameters at the
Time of CMR Examination
Aortic valve peak Doppler gradient, mm Hg 36 (0–90)
Aortic regurgitation fraction, % 25 (0–48)
LV ejection fraction, % 63 (48–79)
LV end-diastolic volume, ml/m2 104 (52–201)
LV mass/BSA, g/m2 72 (37–163)
LV mass/volume, g/ml 0.66 (0.45–0.96)
Late gadolinium enhancement 8 (24)
Values are median (range) or n (%).
BSA ¼ body surface area; CMR ¼ cardiac magnetic resonance; LV ¼ left ventricular.
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at Boston Children’s Hospital (unpublished data, S. Colan,
November 2013). LA volume was measured from apical
4- and 2-chamber views using the biplane area-length
calculation (15) and indexed to body surface area1.4 (16).
Cardiac catheterization. The cardiac catheterization data
closest in time to the CMR examination were reviewed if
they were performed within 1 year of the CMR and no
intervening cardiac interventional procedures were per-
formed. The LA, LV end-diastolic pressure, and the pul-
monary capillary wedge pressure (PCWP) were recorded for
each case.
Exercise testing. The exercise test closest in time to the
CMR examination was reviewed if it was performed within
1 year of the CMR and no intervening cardiac interventional
procedures were performed. Testing was performed on
either a progressive bicycle ergometer or a treadmill using a
standard Bruce protocol, with analysis of expiratory gases
using a metabolic cart (Medical Graphics Corporation,
St. Paul, Minnesota). Subjects were excluded if they failed to
reach a peak respiratory exchange ratio 1.1 (indicating
submaximal effort) or if the reason for termination was other
than fatigue. The peak oxygen consumption (VO2) and peak
heart rate were recorded.
Statistical analysis. Patient characteristics and clinical data
were reported as medians and ranges for continuous vari-
ables and percents for categorical variables. The Mann-
Whitney test was used to compare ECV in AS and
control subjects and to explore the association of ECV and
LGE with other parameters. The Spearman rank correlation
was used to determine the relationship between ECV and
the spectral Doppler velocities, tissue Doppler imaging
velocities, LA volume, LV end-diastolic pressure, PCWP,
and age. All statistical tests were 2-sided. For the primary
comparison of ECV in AS patients versus control subjects,
results were considered signiﬁcant if p < 0.05. When
exploring the relationship of ECV and LGE with various
clinical parameters, signiﬁcance was set at p < 0.01 to ac-
count for multiple comparisons. ECV data for the control
subjects was tested for normality using a quantile-quantileplot and evaluating the quantile distribution. Analyses
were performed using SPSS version 19.0.0 (SPSS Inc.,
Chicago, Illinois).
Results
Subjects. A total of 35 AS subjects met the study inclusion
criteria. Their demographics and history are shown in
Table 1, and their echocardiographic and CMR data are
shown in Table 2. Of note, the median age at the time of
CMR examination was 16.0 years (range 1.7 to 27 years),
and 83% were male. Although the degree of AS at the time
of CMR was relatively mild (median peak Doppler gradient
36 mm Hg), there was often a history of more severe aortic
valve obstruction (median peak gradient at any time prior to
the CMR examination 70 mm Hg) and a high prevalence
of prior interventional procedures to treat this (80%). No
subject had undergone a surgical procedure (e.g., ventricular
septal defect closure) that directly involved the mid-
ventricular myocardium where the myocardial T1 measure-
ments were performed. For the 27 control subjects, the
median age at the time of CMR examination was 16.0 years
(range 8 to 20 years) and 56% were male.
Myocardial ECV. The median myocardial ECV was 0.27
(range 0.22 to 0.42) in the AS subjects and 0.25 (range 0.18
to 0.27) in the control subjects (Fig. 1). The ECV in AS
subjects was signiﬁcantly greater than in control subjects (p¼
0.001). The ECV data in the control subjects was normally
distributed with a mean of 0.24  0.02. Using 2 SDs above
the mean control ECV as the upper limit of normal (0.28),
13 (37%) of the AS subjects had an increased ECV. In the
AS patients, there was no signiﬁcant difference among the
segmental ECVs (p ¼ 0.37). Intraobserver variability for
ECV calculation was assessed in 10 AS and 5 control subjects
who were randomly selected. The ECV mean difference was
0.014  0.012, and the intraclass correlation coefﬁcient was
0.95 (95% conﬁdence interval: 0.85 to 0.98).
Late gadolinium enhancement. LGE imaging was per-
formed in 34 subjects, and areas of LGE were present in 8
(24%). Among these, a conﬂuent layer of only sub-
endocardial LGE involving 12 segments was seen in 3
subjects (Figs. 2A to 2D). The remaining subjects had an
LGE distribution as follows: midwall in the basal-inferior
segment (n ¼ 1) (Figs. 2E and 2F), transmural in 4 small
Figure 1 ECV in Congenital AS Versus Control Subjects
Extracellular volume fraction (ECV) in control (n ¼ 27) and aortic stenosis (AS)
(n ¼ 35) subjects. ECV is signiﬁcantly larger in AS subjects than in control subjects
(p ¼ 0.001).
Figure 2 LGE in Congenital AS
Late gadolinium enhancement (LGE) images in 4 subjects with congenital aortic
stenosis (AS) shown in ventricular short- (A, C, E, and G) and long-axis (B, D, F,
and H) views. Two subjects (A to D) have a conﬂuent layer of subendocardial
hyperenhancement of the LV myocardium. The third subject (E and F) has a focal
region of hyperenhancement in the midwall of the LV basal-inferior segment. The
fourth subject (G and H) has hyperenhancement of the posteromedial papillary
muscle and an apical muscle band.
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septum and endocardial surface of noncompacted myocar-
dium (n ¼ 1), and posteromedial papillary muscle and an
apical muscle band (n ¼ 1) (Figs. 2G and 2H). Subjects with
LGE had a greater ECV than those without (0.34 vs. 0.25,
p ¼ 0.017). In the 3 subjects with conﬂuent subendocardial
LGE, the median ECV (excluding regions of LGE) was
0.35 (range 0.28 to 0.35). This value was not signiﬁcantly
different than the ECV in the other 5 patients with LGE
(median 0.34; range 0.23 to 0.42; p ¼ 1.0) or the ECV for
all 32 AS patients without subendocardial LGE (median
0.34; range 0.23 to 0.42; p ¼ 0.07). LGE was not found in
any of the control subjects.
Diastolic function. Echocardiograms were available in all
patients within a median of 34 days (range 0 to 273 days) of
the CMR study. No cardiac interventional procedures
occurred between the CMR and echocardiogram examina-
tions. The correlations between ECV and spectral Doppler
mitral velocities, tissue Doppler imaging velocities, and
indexed LA volumes are shown in Table 3; Doppler data in 5
subjects and LA measurements in 2 subjects were not
available or of suboptimal quality. The age-adjusted echo-
cardiographic parameters that were signiﬁcantly correlated
with ECV were the mitral E-wave velocity z-score (r ¼ 0.58,
p ¼ 0.002), E/septal E0 z-score (r ¼ 0.56, p ¼ 0.003)
(Fig. 3), E/mean E0 z-score (r ¼ 0.55, p ¼ 0.003), and
indexed LA volume by echo (r ¼ 0.56, p ¼ 0.001) (Fig. 4).
Compared with subjects with normal ECV values (0.28),
those with an elevated ECV (>0.28) had a signiﬁcantly lower
septal E0 z-score (3.68 vs. 2.63, p ¼ 0.0.007), higher E/
septal E0 z-score (8.42 vs. 3.21, p ¼ 0.001), higher E/meanE0 z-score (9.55 vs. 4.04, p ¼ 0.008), and larger indexed LA
volume by echo (54.2 ml/m2 vs. 26.5 ml/m2, p ¼ 0.006).
The associations between the presence and absence of
LGE and spectral Doppler mitral velocities, tissue Doppler
velocities, and indexed LA volume are shown in Table 3.
The presence of LGE was signiﬁcantly associated with a
lower septal E0 z-score (p < 0.001), and a higher E/septal E0
z-score (p ¼ 0.001).
Contemporaneous catheterization data were available in
21 subjects within a median of 50 days (range 0 to 337 days)
Table 3 Correlation of ECV and LGE With Diastolic Function Parameters
Median (Range)
ECV LGE
rs p Value p Value
Mitral valve Doppler (n ¼ 27)
E (cm/s) 97.5 (56.7 to 162.0) 0.57 0.002 0.063
E z-score 0.2 (2.1 to 3.8) 0.58 0.002 0.041
A (cm/s) 39.2 (30.9 to 110.6) 0.42 0.034 0.28
A z-score 0.6 (1.7 to 5.6) 0.40 0.041 0.33
E/A ratio 2.2 (1.1 to 4.2) 0.094 0.65 0.31
E/A z-score 0.1 (1.4 to 3.2) 0.061 0.77 0.17
LV lateral TD (n ¼ 27)
E0 (cm/s) 8.7 (3.2 to 14.0) 0.46 0.013 0.23
E0 z-score 3.4 (5.0 to 1.7) 0.25 0.21 0.72
A0 (cm/s) 4.1 (2.3 to 6.8) 0.091 0.65 0.15
A0 z-score 0.9 (2.0 to 0.6) 0.031 0.88 0.081
LV septal TD (n ¼ 27)
E0 (cm/s) 7.2 (3.6 to 11.6) 0.52 0.006 <0.001
E0 z-score 3.0 (4.9 to 1.0) 0.49 0.01 <0.001
A0 (cm/s) 4.8 (1.9 to 6.9) 0.081 0.69 0.022
A0 z-score 0.6 (2.6 to 0.9) 0.076 0.71 0.016
LV mean TD (n ¼ 27)
E0 (cm/s) 8.2 (3.4 to 12.8) 0.55 0.003 0.005
E0 z-score 3.6 (5.5 to 1.6) 0.43 0.024 0.031
LV E/E0 (n ¼ 27)
E/lateral E0 11.4 (6.5 to 37.3) 0.59 0.001 0.036
E/lateral E0 z-score 4.9 (1.3 to 25.2) 0.49 0.010 0.145
E/septal E0 12.6 (6.1 to 34.3) 0.57 0.002 0.001
E/septal E0 z-score 3.6 (0.6 to 13.3) 0.56 0.003 0.001
E/mean E0 11.3 (6.3 to 34.6) 0.63 <0.001 0.008
E/mean E0 z-score 5.2 (0.5 to 20.7) 0.55 0.003 0.022
Echo LA volume, ml/m2 (n ¼ 30) 30.0 (9.2 to 101.1) 0.56 0.001 0.013
CMR LA volume, ml/m2 (n ¼ 35) 37.0 (21.6 to 149.4) 0.42 0.018 0.026
LVEDP, mm Hg (n ¼ 21) 23.1 (11.0 to 42.0) 0.23 0.32 0.34
PCWP, mm Hg (n ¼ 20) 16.9 (9.0 to 30.0) 0.041 0.87 0.61
Echo¼ echocardiographic; LA¼ left atrial; LGE¼ late gadolinium enhancement; LVEDP¼ left ventricular end-diastolic pressure; PCWP¼ pulmonary
capillary wedge pressure; rs ¼ Spearman rank correlation coefﬁcient; TD ¼ tissue Doppler; other abbreviations as in Table 2.
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catheterization were AS (n ¼ 16, median peak AS gradient
50 mm Hg), aortic regurgitation (n ¼ 2), respiratory failure
(n ¼ 1), coarctation (n ¼ 1), and severe diastolic dysfunction
by echocardiography (n ¼ 1). ECV was not signiﬁcantly
correlated with LV end-diastolic pressure or PCWP
(Table 3). LGE was present in 8 subjects and was not
signiﬁcantly associated with LV end-diastolic pressure or
PCWP (Table 3).
LV and aortic valve function. CMR measurements of LV
ejection fraction, indexed end-diastolic volume, indexed
mass, and mass/volume ratio did not signiﬁcantly correlate
with ECV or LGE. The aortic valve peak and mean
continuous-wave Doppler gradient at the time of CMR
were not signiﬁcantly correlated with ECV or the presence
of LGE. Similarly, in the subgroup of subjects who had a
contemporaneous catheterization, the peak aortic valve
gradient by catheterization was not signiﬁcantly correlated
with ECV or the presence of LGE. The CMR measure-
ment of aortic regurgitation fraction did not signiﬁcantly
correlate with ECV or the presence of LGE.Exercise testing. Contemporaneous exercise test results
were available in 11 subjects within a median of 40 days
(range 0 to 301 days) of the CMR examination. ECV was
not signiﬁcantly associated with peak VO2 (r ¼ 0.52, p ¼
0.10). Compared with subjects with a normal ECV (n ¼ 7),
those with an elevated ECV (n ¼ 4) tended to have a lower
peak VO2 (38.7 ml/kg/min vs. 25.8 ml/kg/min, p ¼ 0.024).
LGE was present in only 1 subject with exercise test results
precluding meaningful analysis.
Demographics and history. Patients with an elevated
ECV (>0.28) had a greater number of aortic valve in-
terventions (p ¼ 0.004) and a greater number of aortic
balloon valvuloplasties (p ¼ 0.003), and those with LGE
were younger at the time of CMR (p ¼ 0.002). The
following other factors were not associated (p  0.01) with
an elevated ECV or LGE: age at ﬁrst aortic surgery or
balloon valvuloplasty, history of any cardiac surgery,
highest aortic valve gradient by echocardiography at any
time, and degree of aortic valve regurgitation at CMR.
Eight patients were prescribed an angiotensin-converting
enzyme inhibitor, 1 an angiotensin receptor blocker, and 2
Figure 3 ECV Versus E/Septal E0 Z-Score
Relationship between extracellular volume fraction (ECV) and left ventricular
E/septal E0 ratio z-score in subjects with aortic stenosis (n ¼ 27). rs ¼ Spearman
rank correlation coefﬁcient.
Figure 4 ECV Versus Indexed LA volume
Relationship between extracellular volume fraction (ECV) and indexed left atrial
(LA) volume by echocardiography in aortic stenosis subjects (n ¼ 30). Abbrevia-
tions as in Figure 3.
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1783spironolactone. The ECV of the 8 patients prescribed an
angiotensin-converting enzyme inhibitor was not signiﬁ-
cantly different than that of the 24 patients who were taking
no medications (p ¼ 0.26).
Discussion
This study is the ﬁrst to examine myocardial ECV by CMR
T1 measurement and LGE in a cohort of children and
young adults with congenital AS. We found that the ECV
was elevated in approximately one-third and that LGE was
present in approximately one-quarter of the subjects. ECV
by T1 measurement has been shown to be closely correlated
with myocardial collagen fraction quantiﬁed by histopa-
thology in adults with AS and is thus thought to represent
diffuse ﬁbrosis in this setting (10,17,18). LGE has been
demonstrated to coincide with regions of focal myocardial
ﬁbrosis in a variety of conditions (5,19). Our data thereby
indicate that both focal and diffuse myocardial ﬁbrosis are
present in a subset of patients with congenital AS. We also
found that higher ECV and the presence of LGE were both
associated with echocardiographic indexes of diastolic
dysfunction. Our results underscore the notion that AS in
children and young adults is accompanied by important
myocardial abnormalities.
Previous studies. One other group has reported the range
and associations of ECV in AS patients using a CMR
T1 measurement technique, and that was in a considerably
older cohort (median age 67 years) (10,17,18). They found
that ECV in AS patients was signiﬁcantly greater than in
the normal subjects (0.276  0.044 vs. 0.253  0.035,
p < 0.03) (18). A higher ECV correlated with a smaller
aortic valve area but not with the mean and peak aortic valve
velocities, LV ejection fraction, LV mass, LA area, or extent
of LGE (17).Several studies have reported the presence of LGE in
adults with AS with a prevalence ranging from 27% to
66% (18,20–24). Reports on focal myocardial ﬁbrosis by
CMR in young patients with congenital AS are more
limited (25,26). We have previously reported a case series of
4 teenage patients with congenital AS who developed severe
diastolic heart failure and were found to have a conﬂuent
subendocardial layer of LGE (25). In the 2 patients for
whom pathology specimens were available, the LGE
correlated with endocardial ﬁbroelastosis. Similarly, we
previously reported that this same subendocardial LGE
pattern was related to endocardial ﬁbroelastosis in patients
with prenatally-diagnosed AS who underwent in utero
balloon aortic valvuloplasty (26). In the current study, 3 of 8
of the subjects with LGE had the same extensive sub-
endocardial distribution; based on our earlier experience and
similar published ﬁndings (27), this also likely indicates
endocardial ﬁbroelastosis.
Clinical implications. It is interesting that myocardial
ﬁbrosis was present in our cohort even though at the time of
CMR the degree of AS was relatively modest with a median
peak gradient of 36 mm Hg. Subjects, however, often had a
history of more severe AS prior to interventions, with a
median peak gradient at any time prior to the CMR ex-
amination of 70 mm Hg. This observation suggests that
myocardial ﬁbrosis will persist to some degree despite a
reduction in the pressure load. This notion is consistent with
a study in adults with AS in which the extent of myocardial
ﬁbrosis by ECV measurement was unchanged 6 months
following aortic valve replacement (17). Longitudinal studies
are needed to conﬁrm this assertion in children and to
determine whether earlier intervention to relieve AS will
reduce the extent of ﬁbrosis.
The clinical implications of ﬁnding an elevated ECV or
LGE in a patient with congenital AS need to be further
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this result should raise concern. LGE is associated with LV
diastolic dysfunction, systolic dysfunction, decreased recov-
ery of LV systolic function following aortic valve procedure,
less improvement in clinical symptoms following aortic valve
procedure, and increased mortality following aortic valve
replacement procedure and overall (20,21,23,24). A higher
ECV in adults with AS is signiﬁcantly related to severe
diastolic dysfunction by echocardiography, worse New York
Heart Association functional class, lower performance on a
6-min walk test, and adverse outcomes following aortic valve
replacement procedure (17).
Given the mounting evidence that myocardial ﬁbrosis has
a negative clinical impact in AS, investigating therapies,
both medical and procedural, that reduce ﬁbrosis is war-
ranted. Knowledge of the impact of aortic valve dilation or
replacement on ﬁbrosis may reﬁne the indications and
timing of these procedures. Drugs that inhibit the trans-
forming growth factor-beta receptor-mediated pathways
(e.g., angiotensin and aldosterone inhibitors) have shown
promise in reversing myocardial ﬁbrosis (28,29). Quantiﬁ-
cation of the ECV by CMR T1 measurement could be used
to identify study candidates with increased myocardial
ﬁbrosis and evaluate therapeutic efﬁcacy over time. Our
work shows that such measurements are technically and
clinically feasible in children and young adults with AS.
Study limitations. Our study has a number of limitations
related to its retrospective design, such as a variable time
interval between echocardiography and CMR. Moreover,
the subjects included may not be representative of children
and young adults with congenital AS because they were
selected from a population that was referred for a CMR
study. ECV measurements were derived from a single
midventricular location. Although this is the same approach
that was used to validate the technique with myocardial
collagen fraction using histopathology (8), it is possible that
there could be regional variation in ECV that went unde-
tected. Establishing the normal range of ECV in children is
challenging because ethical considerations preclude the
administration of gadolinium-based contrast agents exclu-
sively for research. We were thus limited to subjects who
had a clinical indication for contrast administration and no
disease affecting the myocardium. Although the AS and
control subjects were not age-matched, the median age of
both groups was similar. The inclusion of more very young
patients in the AS group than in the control group is un-
likely to be driving the larger ECV in AS because pathology
and CMR studies indicate that ECV increases rather than
decreases with age (11,30). Moreover, it is worth noting that
the ECV mean and SD in our control subjects was similar to
that in a previously published cohort of healthy adult vol-
unteers using the same imaging protocol and measurement
technique (7). The echocardiographic diastolic function
parameters examined in this study were on the basis of
guidelines for adults (16) and may not have the same clinical
signiﬁcance in children. However, 1 study of aortic stenosispatients that included pediatric subjects showed a correlation
between E/E0 and LV end-diastolic pressure (r ¼ 0.58, p <
0.001), with an E/E0 >9.5 predicting LV end-diastolic
pressure of 15 mm Hg with 84% sensitivity and 76%
speciﬁcity (3). Finally, the lack of a signiﬁcant correlation
between ECV and LGE with LV end-diastolic pressure or
PCWP may be related to time differences between cathe-
terization procedures and CMR and insufﬁcient statistical
power, as there were relatively few AS subjects who had a
cardiac catheterization.
Conclusions
This retrospective study of children and young adults with
congenital AS referred for CMR showed that an elevated
ECV and LGE were present in 37% and 24% of subjects,
respectively. These ﬁndings strongly suggest that both
diffuse and focal ﬁbrosis are associated with congenital AS
and present at a young age. Moreover, a higher ECV and
LGE were associated with echocardiographic indexes of
diastolic dysfunction. Together, these results highlight the
adverse role of myocardial ﬁbrosis in congenital AS and the
need for speciﬁc therapies or management strategies to
minimize it. Future studies may evaluate the utility of ECV
and LGE in guiding management and measuring the efﬁcacy
of novel therapies for treatment of myocardial ﬁbrosis.
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